This page is part of the Pharmaceutical Quality (Industry) (v1.0.0: STU1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Generated Narrative: Composition
Resource Composition "composition-drug-pq-risk"
Profile: Composition - Drug PQ
status: final
type: Product Note - Summary for Risk of Impurities ()
date: 2023-10-01
author: Organization/organization-drug-pq-ex1 "AAA Molybdenum Products, Inc."
title: 3.2.P.2.2.4 - Summary for Risk of Impurities